New drug mediates side effects of stroke treatment
Researchers at Joslin Diabetes Center (Boston, MA, USA) have investigated the utilization of a drug in combination with thrombolytic treatment to potentially improve stroke outcomes.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.